The UK pharmaceutical sector is set to get its own body dedicated to identifying and addressing key skills issues. A …
CRO Synexus has doubled its head office capacity as it continues to grow across the UK, Central and Eastern Europe, …
A new online monitoring service will provide pharmaceutical decision-makers with briefings on opportunities and threats to their businesses coming from …
Bristol Myers-Squibb's earnings growth massively outstripped its income in the second quarter of the year. The company saw its net …
Digital marketing in all its forms can no longer be regarded the preserve of the 'early adopters' or young people …
The effect of the swine flu pandemic has boosted Roche's half-year results, adding to figures already strengthened by the company's …
The prospects for future funding of the NHS "now look bleak", according to a new report by the King's Fund …
The contamination problems at Genzyme's Allston Landing production plants have caused the firm to scale back its revenue forecasts for …
Event management agency WorldEvents has opened a new office in Switzerland. It has recruited Uwe Bornemann, an experienced event professional, …
Merck and Schering-Plough's legal battles with their shareholders may be approaching a truce. Two class action lawsuits earlier this year …
GlaxoSmithKline has signed a major deal with Amgen to co-market its new osteoporosis treatment denosumab in Europe, Australia, New Zealand …
The first crop of second-quarter figures from the contract research sector reveals a mixed bag, with PPD and Icon affected …

The Niagara Falls are one of the wonders of the natural world, and every year millions of visitors from around …
US pharmaceutical services firm AAIPharma has sold its drug development division to a private equity firm in another example of …
Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Takeda, Merrion Pharma, Cambridge Major, Dendreon and GlaxoSmithKline, …
Over the last two years the UK pharma industry's established product sales strategies have begun to change. The industry's primary …
UK contract development and manufacturing company NextPharma has won a preliminary green light from the authorities in Belgium for its …
Merck & Co's new manufacturing facility in Durham, North Carolina, is on schedule to start production of vaccines in the …